Suite 506, Level 5 50 Clarence Street, Sydney NSW 2000, Australia hello@breathelifesciences.com +61 2 9078 8180 23 October 2026 ANNUAL GENERAL MEETING NOTICE AND PROXY FORM Dear Shareholder, The Annual General Meeting (Meeting) of shareholders of Bioxyne Limited (ACN 084 464 193) (Company) will be...
Letter to Shareholders re Annual General Meeting
Filed with ASX · · 2 pages · English
Release
BLS Pharmaceuticals Limited on 6ix
Earlier from BLS Pharmaceuticals
- Notice of Annual General Meeting/Proxy Form
- Q1 FY2027 Quarterly Activities Update
- BLS Quarterly Activities Report September 2026 Revised
- Quarterly Activities/Appendix 4C Cash Flow Report
- Ceasing to be a substantial holder